STOCK TITAN

Integra LifeSciences to Present at 41st Annual J.P. Morgan Healthcare Conference

Integra LifeSciences (NASDAQ: IART) announced that its CEO, Jan De Witte, will present at the 41st Annual J.P.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

Integra LifeSciences (NASDAQ: IART) announced that its CEO, Jan De Witte, will present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023, at 7:30 PM ET. A live webcast will be accessible through Integra's investor relations website. The company, recognized for its regenerative tissue technologies and neurosurgical solutions, aims to support clinicians in delivering optimal patient care. Integra boasts a robust portfolio of high-quality brands.

Loading...
Loading translation...
Argus Session date unavailable
+0.07% session move Open Argus
Details

News Market Reaction – IART

The recorded move for IART in the trading session of this news was +0.07%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

PRINCETON, N.J., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Jan De Witte, president and chief executive officer will present at the 41st Annual J.P. Morgan Healthcare conference on January 11, 2023 at 7:30pm ET.

A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at http://investor.integralife.com/events-and-presentations.

About Integra LifeSciences
Integra LifeSciences is a global leader in regenerative tissue technologies and neurosurgical solutions dedicated to limiting uncertainty for clinicians so they can focus on providing the best patient care. Integra offers a comprehensive portfolio of high quality, leadership brands that include AmnioExcel®, Bactiseal®, BioD™, CerebroFlo®, CereLink® Certas® Plus, Codman®, CUSA®, Cytal®, DuraGen®, DuraSeal®, Gentrix®, ICP Express®, Integra®, Licox®, MAYFIELD®, MediHoney®, MicroFrance®, MicroMatrix®, NeuraGen®, PriMatrix®, SurgiMend®, TCC-EZ® and VersaTru®. For the latest news and information about Integra and its products, please visit integralife.com.

CONTACTS:
Investor Relations:
Chris Ward (609) 772-7736
chris.ward@integralife.com

Media:
Laurene Isip (609) 208-8121
laurene.isip@integralife.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Integra LifeSciences presenting at the J.P. Morgan Healthcare Conference?

Integra LifeSciences will present on January 11, 2023, at 7:30 PM ET.

Where can I watch the Integra LifeSciences presentation?

The presentation will be available via live webcast on Integra's investor relations website.

Who is the CEO of Integra LifeSciences?

Jan De Witte is the CEO of Integra LifeSciences.

What is the stock symbol for Integra LifeSciences?

The stock symbol for Integra LifeSciences is IART.

What types of products does Integra LifeSciences offer?

Integra LifeSciences offers a comprehensive portfolio, including regenerative tissue technologies and neurosurgical solutions.

Keep reading